MediPharm Labs Corp., a pharmaceutical company specialized in precision-based cannabinoids, is has entered into a licencing agreement with Remidose Aerosols (Remidose) to acquire the exclusive rights for advanced cannabis products.
DKSH Acquires Healthcare Distributor Medipharm in Brunei
MediPharm Labs Settles an Outstanding Claim for $9M
MediPharm Labs Launches New GMP Products to the Australian Medical Cannabis Market
MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement
MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth
MediPharm Welcomes News from the U.S. Government